The treatment was created in collaboration with AbCellera, a biotechnology company based in Canada. When someone recovers from a disease like ...
News
- National coronavirus updates: First human trial of potential antibody treatment begins
- Gilead says drug helped moderately ill coronavirus patients
WASHINGTON (AP) — A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to ...
- Other news to note for June 1, 2020
Celonova Biosciences Inc., of San Antonio, Texas, completed enrollment of the COBRA REDUCE randomized control trial evaluating the safety and ...
- Coty, Beyond Meat rise; Pfizer, Gilead Sciences fall
The latest results from the biotechnology company's study of a potential COVID-19 treatment disappointed investors. Beyond Meat Inc., up $10.40 to ...
- Lockdowns ease in Florida, Europe with new tourism rules
Meanwhile, a California biotech company said its experimental drug remdesivir improved symptoms when given for five days to moderately ill, ...